Skip to content
10-K

Annual Report

AMEXDRUG CORP

0001096906-12-000765

← back to feed
Filed
Mar 30, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Mar 23, 2012 8.47M sh
Shares Diluted FY 2011 · Dec 31, 2011 8.47M sh
Shares Diluted FY 2011 · Dec 31, 2010 8.47M sh
Cash And Equivalents FY 2011 · Dec 31, 2011 $589.47K
Cash And Equivalents FY 2011 · Dec 31, 2010 $443.7K
Cash And Equivalents FY 2011 · Dec 31, 2009 $121.18K
Stock Repurchased FY 2011 · Dec 31, 2010 $2.16K
Capex FY 2011 · Dec 31, 2010 $4.04K
Operating Cash Flow FY 2011 · Dec 31, 2010 $226.78K
Current Liabilities FY 2011 · Dec 31, 2010 $1.09M
Current Assets FY 2011 · Dec 31, 2010 $1.29M
Total Assets FY 2011 · Dec 31, 2010 $1.34M
Sga Expense FY 2011 · Dec 31, 2010 $664.15K
Net Income FY 2011 · Dec 31, 2010 $189.06K
Operating Income FY 2011 · Dec 31, 2010 $290.43K
Gross Profit FY 2011 · Dec 31, 2010 $962.68K
Cost Of Revenue FY 2011 · Dec 31, 2010 $10.52M
Revenue FY 2011 · Dec 31, 2010 $11.49M
Stockholders Equity FY 2011 · Dec 31, 2009 $63.6K